人工智能数字病理算法通过前列腺、肺、结直肠和卵巢癌症试验预测根治性前列腺切除术后的生存
本研究基于前列腺、肺、结直肠和卵巢癌症筛查随机对照试验中1032例接受根治性前列腺切除术并具有数字化病理图像的患者,评估锁定多模态人工智能算法预测前列腺癌特异性死亡和总生存的能力。中位随访17年,前列腺癌特异性死亡和远处转移算法均预测前列腺癌特异性死亡(HR 2.31,95%CI 1.6-3.35,P<.001;HR 1.96,95%CI 1.35-2.85,P<.001),也预测总生存(HR 1.22,95%CI 1.01-1.47,P=.04;HR 1.19,95%CI 1.02-1.4,P=.03)。
要点
- 锁定多模态人工智能算法在前列腺活检标本上开发,应用于根治性前列腺切除术标本仍能预测前列腺癌特异性死亡和总生存。
- 前列腺癌特异性死亡算法预测前列腺癌特异性死亡HR为2.31(95%CI 1.6-3.35,P<.001)。
- 远处转移算法预测总生存HR为1.22(95%CI 1.01-1.47,P=.04)。
核心结论
- 锁定多模态人工智能算法先前在前列腺癌放疗患者活检标本上开发和验证,应用于手术治疗患者的根治性前列腺切除术标本时成功预测临床结局。
- 多模态人工智能模型和其他生物标志物可能有助于选择可能从术后雄激素剥夺治疗或放疗强化治疗中获益的患者。
研究设计与样本
- 前列腺、肺、结直肠和卵巢癌症筛查随机对照试验于1993年至2001年将受试者随机分配至癌症筛查组或对照组。
- 识别出接受根治性前列腺切除术且具有可用数字化组织病理学图像和后续生存数据的部分患者,共1032例,中位随访17年(IQR 14.3,19.3年)。
- 评估最初在活检切片上针对接受放疗患者训练的前列腺癌特异性死亡和远处转移多模态人工智能算法对前列腺癌特异性死亡和总生存的预测能力。
- 采用Cox比例风险模型和Kaplan-Meier生存曲线分析。
主要发现
- 前列腺癌特异性死亡多模态人工智能算法预测前列腺癌特异性死亡:HR 2.31(95%CI 1.6-3.35,P<.001)。
- 远处转移多模态人工智能算法预测前列腺癌特异性死亡:HR 1.96(95%CI 1.35-2.85,P<.001)。
- 远处转移多模态人工智能算法预测总生存:HR 1.22(95%CI 1.01-1.47,P=.04)。
- 前列腺癌特异性死亡多模态人工智能算法预测总生存:HR 1.19(95%CI 1.02-1.4,P=.03)。
临床怎么用
- 原文结论指出多模态人工智能模型和其他生物标志物可能有助于选择可能从术后雄激素剥夺治疗或放疗强化治疗中获益的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Clinical variables alone have limited ability to determine which patients will have recurrence after radical prostatectomy (RP). We evaluated the ability of locked multimodal artificial intelligence (MMAI) algorithms trained on prostate biopsy specimens to predict prostate cancer-specific mortality (PCSM) and overall survival (OS) among patients undergoing RP with digitized RP specimens. MATERIALS AND METHODS: The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Randomized Controlled Trial randomized subjects from 1993 to 2001 to cancer screening or control. A subset of patients who underwent RP with available digitized histopathological images and subsequent survival data were identified. Distant metastasis (DM) and PCSM MMAIs originally trained on biopsy slides for patients undergoing radiation were evaluated for prediction of PCSM and OS. Cox proportional hazards modeling and Kaplan-Meier survival curve analysis were used. RESULTS: In total, 1032 patients who underwent RP with median follow-up of 17 years (IQR, 14.3, 19.3 years) were identified. MMAI algorithms for PCSM and DM both predicted PCSM (HR, 2.31, 95% CI, 1.6-3.35, P < .001 and HR, 1.96, 95% CI, 1.35-2.85, P < .001, respectively). Similarly, DM and PCSM MMAI predicted OS (HR, 1.22, 95% CI, 1.01-1.47, P = .04 and HR, 1.19, 95% CI, 1.02-1.4, P = .03). CONCLUSIONS: Locked MMAI algorithms previously developed and validated on biopsy specimens from patients undergoing radiation for prostate cancer successfully predicted clinical outcomes when applied to RP specimens from patients treated with surgery. MMAI models and other biomarkers may help select patients who may benefit from postoperative treatment intensification with androgen deprivation therapy or radiation.
引用
- Li EV, Ren Y, Griffin J, et al. An Artificial Intelligence-Digital Pathology Algorithm Predicts Survival After Radical Prostatectomy From the Prostate, Lung, Colorectal, and Ovarian Cancer Trial. J Urol. 2025. PMID: 39841869. doi:10.1097/JU.0000000000004435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。